rs1292011: Understanding the 12q24 Breast Cancer Risk Association
The genetic variant rs1292011 is a single nucleotide polymorphism located in an intergenic region on chromosome 12. Research has identified this variant as being associated with an increased risk of developing estrogen receptor-positive breast cancer.
What each genotype means
Baseline breast cancer risk
This genotype represents the baseline risk profile for this specific genetic location. Research indicates that individuals with this genotype do not carry the specific allele associated with increased susceptibility to estrogen receptor-positive breast cancer. Please note that breast cancer risk is multifactorial, involving many genetic and environmental factors, and this result should not be interpreted as a guarantee of health.
This genotype is common in many populations, though exact frequencies vary significantly by ancestry.
Slightly increased risk profile
Carrying one copy of the G allele at this location is associated with a statistically higher risk of developing estrogen receptor-positive breast cancer compared to those without it. This association has been observed across both European and Chinese populations. It is important to remember that this is a small component of overall risk, and you should discuss your personal and family health history with a clinician to determine appropriate screening schedules.
This heterozygous genotype is found in a significant portion of the population, consistent with the reported minor allele frequency of 0.11 to 0.41.
Increased breast cancer risk
Carrying two copies of the G allele is associated with an increased risk of developing estrogen receptor-positive breast cancer. While this variant is a recognized susceptibility locus, it is only one of many factors that contribute to breast cancer development. You should maintain regular breast cancer screenings as recommended by your healthcare provider based on your age and overall risk profile.
This genotype occurs at a frequency consistent with the reported minor allele frequency range, appearing in a notable percentage of the population.
What is rs1292011?
The rs1292011 variant is a single nucleotide polymorphism (SNP) located at the 12q24 chromosomal locus. In genetics, a SNP represents a variation at a single position in a DNA sequence among individuals. Because this specific variant is located in an intergenic region—meaning it sits in the space between known protein-coding genes—it does not directly code for a protein itself. Instead, researchers study such variants to understand how they might influence the regulation of nearby genes or serve as markers for other functional changes in the genome. By analyzing these non-coding regions, scientists aim to map the complex genetic architecture that contributes to common health conditions, including various forms of cancer.
Research and Breast Cancer Associations
Scientific studies, including large-scale genome-wide association studies (GWAS), have identified rs1292011 as a susceptibility locus for breast cancer. Evidence suggests that this variant is associated with an increased risk of estrogen receptor-positive breast cancer in the general population. Furthermore, some research has indicated that this variant may also be relevant for individuals who carry BRCA2 mutations, showing a statistical association with breast cancer risk in that specific group. It is important to note that while these associations are statistically significant in research cohorts, they represent a small portion of the overall risk profile for breast cancer. The evidence strength for this association is considered moderate, reflecting the complex, polygenic nature of breast cancer where many small genetic factors contribute to overall susceptibility.
Interpreting Genetic Information
Understanding a variant like rs1292011 requires context. Genetic associations identified in research studies describe trends across large populations rather than individual outcomes. Having a specific genotype at this locus does not mean an individual will develop a condition, nor does it guarantee protection. Because breast cancer risk is influenced by a combination of genetics, lifestyle, and environmental factors, this information should be viewed as one small piece of a much larger puzzle. If you are concerned about your personal risk for breast cancer, it is essential to consult with a healthcare professional or a genetic counselor. They can provide a comprehensive assessment based on your personal and family medical history, which is far more predictive than any single genetic variant.
How common is this variant?
The minor allele frequency for rs1292011 ranges from 0.11 to 0.41 across different global populations, indicating that the variant is relatively common.
Frequently asked questions
Does having the rs1292011 variant mean I will get breast cancer?
No. Genetic variants like rs1292011 are associated with a statistical increase in risk across large populations, but they are not diagnostic. Many other factors, including family history and lifestyle, play a much larger role in determining individual risk.
What should I do if I have the 'higher-attention' genotype?
You should continue to follow standard breast cancer screening guidelines recommended by your healthcare provider. Genetic associations are not medical diagnoses, and you should discuss your overall risk profile with a doctor rather than focusing on a single SNP.
Is rs1292011 a gene?
No, rs1292011 is a single nucleotide polymorphism (SNP) located in an intergenic region, which means it is in the DNA between genes. It is not a gene itself and does not produce a protein.
Where can I find more information about breast cancer risk?
For reliable information regarding breast cancer risk factors and screening, you should consult resources like the American Cancer Society or speak directly with your primary care physician or a genetic counselor.
Sources & further reading
Educational information only, last refreshed 10/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1292011?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This variant is classified as probable-pathogenic for spastic ataxia Charlevoix-Saguenay type.
A variant in the EXT2 gene, which is associated with hereditary multiple exostoses.
A variant located in the SPG11 gene, often studied in the context of hereditary spastic paraplegia.
A common variant in the NEB gene frequently annotated in clinical databases.
This variant at the 12p11 locus is associated with breast cancer susceptibility in both estrogen receptor-positive and negative cases.
This variant at the 21q21 locus is associated with an increased risk of estrogen receptor-positive breast cancer.